Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

Clinical Pharmacokinetics
R RivaA A Baruzzi

Abstract

Antiepileptic drug interactions represent a common clinical problem which has been compounded by the introduction of many new compounds in recent years. Most pharmacokinetic interactions involve the modification of drug metabolism; the propensity of antiepileptic drugs to interact depends on their metabolic characteristics and action on drug metabolic enzymes. Phenobarbital, phenytoin, primidone and carbamazepine are potent inducers of cytochrome P450 (CYP), epoxide hydrolase and uridine diphosphate glucuronosyltransferase (UDPGT) enzyme systems; oxcarbazepine is a weak inducer of CYP enzymes, probably acting on a few specific isoforms only. All stimulate the rate of metabolism and the clearance of the drugs which are catabolised by the induced enzymes. Valproic acid (valproate sodium) inhibits to different extents many hepatic enzyme system activities involved in drug metabolism and is able to significantly displace drugs from plasma albumin. Felbamate is an inhibitor of some specific CYP isoforms and mitochondrial beta-oxidation, whereas it is a weak inducer of other enzyme systems. Topiramate is an inducer of specific CYP isoforms and an inhibitor of other isoforms. Ethosuximide, vigabatrin, lamotrigine, gabapentin and possi...Continue Reading

Citations

Jun 26, 2001·European Journal of Drug Metabolism and Pharmacokinetics·K M MatarM I al-Hassan
Nov 25, 2005·European Journal of Clinical Pharmacology·M Strolin BenedettiF Tonner
Jul 28, 2006·European Journal of Clinical Pharmacology·A M AlmeidaM M Caramona
Aug 24, 2012·Forensic Science, Medicine, and Pathology·Jineane V VenciFran M Gengo
Oct 28, 1998·Journal of Psychiatric Research·A ErfurthJ Walden
Mar 23, 1999·Pharmaceutica acta Helvetiae·K M MatarA Tekle
Jan 11, 2001·Pharmacology & Therapeutics·R D MacPherson
Oct 27, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·R MandrioliM A Raggia
Dec 12, 2001·Epilepsy Research·D OuelletE Garofalo
Apr 8, 1999·Epilepsy Research·R CangerL Guidolin
Dec 10, 1998·British Journal of Pharmacology·O E Della PaschoaM Danhof
Jan 12, 1999·British Journal of Pharmacology·O E Della PaschoaM Danhof
Jul 15, 1998·British Journal of Clinical Pharmacology·H L McLeod
Dec 29, 1998·Journal of Clinical Pharmacy and Therapeutics·A M AlmeidaM M Caramona
Jun 24, 1999·Journal of Clinical Pharmacy and Therapeutics·E Tanaka
May 13, 1999·Journal of Clinical Pharmacy and Therapeutics·B B SerranoA Domínguez-Gil
Jul 18, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J GarrardI Leppik
Jan 1, 2010·BMJ Case Reports·Kamini Vasudev, Heinz Grunze
May 9, 2002·Biological & Pharmaceutical Bulletin·Lih-Chi ChenKun-Ying Yen
Aug 11, 2000·Pharmacotherapy·W R Garnett
Jul 25, 2000·Pharmacotherapy·Y KatoS R Kayser
Sep 12, 2002·Clinical Pharmacokinetics·Zeruesenay DestaDavid A Flockhart
Dec 14, 2011·Expert Opinion on Drug Metabolism & Toxicology·Josef Finsterer, Sinda Zarrouk Mahjoub
Aug 26, 1999·Drug Metabolism Reviews·M Strolin Benedetti, M Bani
Mar 30, 2005·Expert Opinion on Drug Safety·Rachel Alsdorf, Diego F Wyszynski
Sep 17, 2005·Journal of Clinical Pharmacy and Therapeutics·G M Peterson, M Naunton
Aug 3, 2006·Journal of Clinical Pharmacy and Therapeutics·S FudioR Ortega
Mar 16, 2001·Expert Opinion on Pharmacotherapy·P H McCabe
May 17, 2005·European Journal of Pharmacology·Jarogniew J LuszczkiStanislaw J Czuczwar
Mar 13, 2002·Seizure : the Journal of the British Epilepsy Association·Kenneth R Kaufman
Nov 10, 2004·Brain & Development·Kenjiro KosakiTakao Takahashi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.